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Tracheobronchomalacia is a common congenital defect in which the walls of the trachea and bronchi lack
of adequate cartilage required for support of the airways. Deletion of Wls, a cargo receptor mediating
Wnt ligand secretion, in the embryonic endoderm using ShhCre mice inhibited formation of tracheal–
bronchial cartilaginous rings. The normal dorsal–ventral patterning of tracheal mesenchyme was lost.
Smooth muscle cells, identiﬁed by Acta2 staining, were aberrantly located in ventral mesenchyme of the
trachea, normally the region of Sox9 expression in cartilage progenitors. Wnt/β-catenin activity, indicated
by Axin2 LacZ reporter, was decreased in tracheal mesenchyme ofWlsf/f;ShhCre/þ embryos. Proliferation of
chondroblasts was decreased and reciprocally, proliferation of smooth muscle cells was increased in
Wlsf/f;ShhCre/þ tracheal tissue. Expression of Tbx4, Tbx5, Msx1 and Msx2, known to mediate cartilage and
muscle patterning, were decreased in tracheal mesenchyme of Wlsf/f;ShhCre/þ embryos. Ex vivo studies
demonstrated that Wnt7b and Wnt5a, expressed by the epithelium of developing trachea, and active
Wnt/β-catenin signaling are required for tracheal chondrogenesis before formation of mesenchymal
condensations. In conclusion, Wnt ligands produced by the tracheal epithelium pattern the tracheal
mesenchyme via modulation of gene expression and cell proliferation required for proper tracheal car-
tilage and smooth muscle differentiation.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
The ventral region of the mammalian trachea is supported by
incomplete circumferential cartilaginous rings and dorsally by the
trachealis smooth muscle. Dorsal–ventral patterning of cartilage
and muscle protects the upper airways from injury and provides
ﬂexibility during ventilation and cough, preventing airway col-
lapse during the respiratory cycle. Tracheobronchomalacia is a
congenital malformation in which the walls of the conducting
airways lack adequate cartilage. While tracheobronchomalacia is a
common disorder (1:3000/live births) (Boogaard et al., 2005;
Kenny et al., 2013), its etiology is poorly understood. Tracheal and
bronchial structures forming the airway are derived from the
anterior foregut endoderm and its interactions with surrounding
mesenchyme, as the airways separate from the esophagus during
the embryonic period at approximately week 12 of gestation in
humans (Fausett and Klingensmith, 2012). Given the prevalence ofte Division of Neonatology,
n’s Medical Center Research
incinnati, OH 45229, USA.
er).tracheobronchomalacia and the challenges associated with cor-
rective surgery, understanding the mechanisms regulating the
formation of the tracheal cartilage will provide the framework to
prevent and treat this condition (Carden et al., 2005; Majid et al.,
2010).
A recent study proposed that the precise apposition of chon-
droblasts and myoblasts establishes the boundaries between car-
tilage and muscle, thus generating a structure needed for rigidity
and ﬂexibility characteristic of the trachea (Hines et al., 2013). It is
presently unclear how dorsal–ventral patterning of developing
tracheal mesenchyme is established. Cartilage development is in-
itiated by the commitment of subsets of mesenchymal cells sur-
rounding the developing trachea, towards a chondrogenic lineage
(McAteer, 1984). Mesenchymal cells derived from the splanchnic
mesoderm, positioned ventral to the developing tracheal tube
express the transcription factor Sox9 as early as E9 (Elluru and
Whitsett, 2004; Hines et al., 2013). Sox9 is a key regulator of car-
tilage and bone development (Akiyama, 2008; Akiyama et al.,
2002) and its role in tracheal cartilage has been demonstrated
(Arora et al., 2012; Elluru and Whitsett, 2004; Hines et al., 2013;
Park et al., 2010; Turcatel et al., 2013). Signaling mechanisms
controlling the initial speciﬁcation of tracheal cartilage progenitors
are poorly deﬁned; however, a number of transcription factors,
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senchyme of the trachea have been identiﬁed. The transcription
factors Tbx4 and Tbx5, expressed by the tracheal mesenchyme
promote Sox9 expression and mesenchymal condensations re-
quired for tracheal cartilage formation (Arora et al., 2012). Shh, a
signaling molecule expressed by the tracheal epithelium, is re-
quired for expression of Sox9 in the ventral tracheal mesenchyme
by a mechanism that involves modulation of Bmp4 signaling
(Miller et al., 2004; Park et al., 2010). Epithelial transcription factor
Sox2 is required for tracheal cartilage formation via induction of
Shh signaling (Que et al., 2009; Tompkins et al., 2009). The calcium
channel Cav3.2, present in both the epithelium and the me-
senchyme of the trachea promotes Sox9 expression via the acti-
vation of the NFAT signaling pathway (Lin et al., 2014). The kinases
Mek1 and Mek2, present in both epithelium and mesenchyme of
developing trachea, induce Sox9 expression via activation of ERK/
MAPK signaling (Boucherat et al., 2014). Mesenchymal Fgf10 and
its epithelial receptor Fgfr2 mediate the periodic pattern of ex-
pression of Shh that inﬂuences the formation of cartilaginous rings
(Sala et al., 2011). Fgf18, expressed by the tracheal mesenchyme,
promotes proliferation of tracheal chondrocytes by inducing Sox9
expression (Elluru et al., 2009). Thus, epithelial–mesenchymal
crosstalk is required for speciﬁcation and differentiation of tra-
cheal cartilage, resembling the mesenchymal–epithelial interac-
tions that govern cell differentiation in developing lung (Shannon
and Hyatt, 2004).
Wnt signaling plays a critical role in speciﬁcation and early
patterning of respiratory tract (Goss et al., 2009; Harris-Johnson
et al., 2009; Miller et al., 2012). Germ line deletion of Wnt5a,
which is expressed in the mesenchyme and epithelium of E11.5
developing trachea, disrupted cartilage rings and caused short-
ening of the trachea (Li et al., 2002). Likewise, ablation of the re-
ceptor ROR2, which mediates Wnt5a-induced Wnt signaling,
caused miss patterning of cartilage and shortening of the trachea
(Oishi et al., 2003). Deletion of β-catenin from the tracheal epi-
thelium caused incomplete cartilaginous rings, while deletion of
β-catenin from the tracheal mesenchyme produced a shorter tra-
chea that underwent degeneration by E18.5 (Bell et al., 2008; De
Langhe et al., 2008; Yin et al., 2008). Deletion of Wnt7b, expressed
by the respiratory epithelium and known to mediate Wnt/β-ca-
tenin signaling, caused incomplete cartilaginous rings (Rajagopal
et al., 2008). Wnt signaling is also critical for proliferation and
differentiation of pulmonary muscle cells (Cohen et al., 2009; De
Langhe et al., 2008; Goss et al., 2011; Shu et al., 2002; Yin et al.,
2008). Wnt7b promotes vascular smooth muscle differentiation
via a mechanism that involves PDGF signaling (Cohen et al., 2009),
while Wnt2, produced by the mesenchyme, promotes differ-
entiation of airway smooth muscle by inducing the expression of
the ligand Fgf10 and Myocd (myocardin), a key regulator of smooth
muscle differentiation (Goss et al., 2011). While the genetic data
support a role for Wnt signaling in tracheal cartilage formation
and suggest a putative role in tracheal muscle differentiation,
precise mechanisms mediating these processes remain unclear.
To deﬁne the role of Wnt signaling in dorsal–ventral patterning
of developing trachea, we generated a mouse model wherein
Wntless (Wls), a cargo receptor that mediates Wnt ligand secretion
(Banziger et al., 2006; Goodman et al., 2006), was conditionally
deleted either in epithelial cells of the foregut endoderm or me-
senchyme of the developing respiratory tract. Epithelial Wls was
required for activation of canonical Wnt signaling in the tracheal
mesenchyme. Wnt ligands produced by epithelial cells of the
conducting airways were required for proper speciﬁcation of the
tracheal bronchial cartilage. Deletion of Wls from the tracheal
epithelium increased proliferation of smooth muscle cells causing
thickening and expansion of the muscle layer into the ventral re-
gion of the trachea at sites where cartilage is normally formed.Thus, epithelial Wnt signaling promotes dorsal–ventral patterning
of the trachea, inﬂuencing differentiation and proliferation of
tracheal cartilage and smooth muscle cells.2. Materials and methods
2.1. Mouse breeding and genotyping
Animals were housed in pathogen-free conditions and handled
according to protocols approved by CCHMC Institutional Animal
Care and Use Committee (Cincinnati, OH USA). Generation of the
Wntless (Wls) conditional knock-out (CKO) mouse has been de-
scribed (Carpenter et al., 2010). Wlsf/f;ShhCre/þ embryos were ob-
tain by breeding Wlsf/f mice with ShhCre mice and breeding the
resulting mice with Wlsf/f mice. Wlsf/f;Dermo1Cre/þ mutants were
generated by breeding Wlsf/f mice with Dermo1Cre mice (Sosic
et al., 2003) and breeding resultant mice with Wlsf/f.
Wlsf/f;ShhCre/þ;Axin2LacZ mice were obtained by mating
Wlsf/þ ;ShhCre/þ with Axin2LacZ(Joeng et al., 2011; Lustig et al.,
2002). Wlsf/f;ShhCre/þ ;Rosa mT/mG mice were generated by
breeding Wlsf/wtShhCreþ /- with Rosa mT/mG mice (Muzumdar et al.,
2007). Wlsf/f;Col2a1Cre/þ mutants were generated by breeding
Wlsf/f mice with Col2a1Cre mice (Ovchinnikov et al., 2000) and
breeding resultant mice with Wlsf/fmice. Sox9f/f;Col2a1Cre/þ and
Sox9f/f;Dermo1Cre/þ embryos were obtained by crossing Sox9f/f
(Kist et al., 2002) with Col2a1Cre or Dermo1Cre and mating re-
sulting mice to Sox9f/fmice. Genotypes of transgenic mice were
determined by PCR using genomic DNA isolated frommouse tail or
embryonic tissue. Primers utilized for genotyping have been pro-
vided as supplementary material (Table S1).
2.2. Histology, immunohistochemistry and immunoﬂuorescence
staining
Embryonic tissue was ﬁxed and embedded in parafﬁn or frozen
using OCT. Sections (6 mm) were processed for H&E or DAB stain-
ing as described (Mucenski et al., 2003). For immunoﬂuorescence,
antigen retrieval was performed, when necessary, using 10 mM
citrate buffer, pH 6, before slides were blocked for 2 h in TBS
containing 10% Donkey serum and 1% BSA. Following blocking,
slides were incubated, overnight, at 4° in primary antibody diluted
accordingly in blocking solution. After removal of unbound pri-
mary antibody, slides were incubated with secondary antibody at a
dilution of 1:200 for one hour. Slides were then washed and
coverslip using Vecta Shield mounting media with or without
Dapi. Fluorescent staining was visualized and photographed using
an automated ﬂuorescence microscope (Zeiss). Source and dilution
of primary antibodies utilized for this study has been provided as
Supplementary data (Table S2).
2.3. Whole mount X-galactosidase staining
Embryonic lungs were dissected and ﬁxed in 4% paraf-
ormaldehyde (PFA) in PBS for 30 min, then washed in PBS and
stained two to three hours in X-gal staining solution. To stop the
reaction, explants were washed in 3% dimethyl sulfoxide-PBS,
rinsed in PBS, washed and stored in 70% ethanol. Explants were
processed for parafﬁn embedding and sectioning. Slides were
deparafﬁnized and counterstained with fast red.
2.4. In-situ hybridization
Procedure was performed according to a protocol developed by
Advanced Cell Diagnostics (ACD) (Wang et al., 2012). In situ probes
were designed by ACD. In brief, slides were baked and
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bridization was performed for 2 h at 40 °C followed by several
rounds of ampliﬁcation steps. Signal was detected by chromogenic
reaction using DAB and slides were counter stained with Hema-
toxylin. All experiments were run simultaneously with a positive
control probe recognizing transcripts for the housekeeping gene
Ppib (which encodes for peptidylpropil isomerase B, an enzyme
found in the endoplasmic reticulum) as well as a negative control
probe that recognizes a bacterial transcript (Dapb). After mounting
with permanent mounting media, slides were photographed using
a wide ﬁeld Nikon i90 microscope.
2.5. Lectin staining
Samples were ﬁxed overnight in PFA and rinsed multiple times
in PBS. Afterwards, samples were incubated for 1 h in blocking
buffer comprised of 2% Goat Serum, 1% BSA, .3% Triton X and PBS.
After removing blocking buffer, lectin PNA solution (in 10% normal
goat serum and PBS) was added to the samples at a ﬁnal con-
centration of 10 mg/ml. The samples were then covered in alumi-
num foil and incubated overnight at 4 °C. Finally, explants were
rinsed with PBS multiple times and photographed using a Leica
ﬂuorescence dissecting microscope.
2.6. Whole mount immunoﬂuorescence staining and confocal
microscopy
Samples were staining as previously described (Ahnfelt-Ronne
et al., 2007). E11.5 and E13.5 tracheal lung explants were isolated
and ﬁxed overnight in 4% PFA and stored in methanol 100%.
Samples were permeabilized using Dent's Bleach and hydrated in a
graded series of methanol. Explants were blocked using a com-
mercial reagent (Invitrogen TSA kit blocking reagent). Primary
antibody was diluted in blocking solution and samples were in-
cubated overnight. After several washes, secondary antibody was
applied for two hours at a 1:500 dilution. After washing, samples
were dehydrated and stored in Methanol. Samples were cleared
with Murray’s clear before imaging (Jahrling et al., 2009; Ott,
2008). Pictures were obtained using a confocal microscope (Ni-
konA1Rsi). Image processing was performed using IMARIS soft-
ware (BITPLANE Scientiﬁc Software).
2.7. Cell proliferation and cell death
E11.5 pregnant mice were injected with BrdU at concentration
100 mg/g of body weight. Embryos were isolated at day E12.5 or
E13.5. Embryonic sections were labeled with BrdU, Nkx2.1, Sox9
and SMA antibodies to determine mitotic cells in tracheal epi-
thelium and mesenchyme. Labeled cells and total cells were
counted per each ﬁeld photograph at 20X, and ratios of pro-
liferating cells to total cells, deﬁned as number of Sox9 and αSΜΑ
stained cells, were calculated. Average mitotic index was de-
termined for ﬁve different samples. To determine cell death, TU-
NEL assay was performed on sections of E12.5, E13.5 and E14.5
embryos using a commercially available detection kit (Roche).
2.8. Embryonic whole tracheal explant culture
Embryonic tracheas were harvested at E11.5 and cultured at
air–liquid interphase as described (Hyatt et al., 2004). Wnt5a,
Wnt3a (200 ng/ml), XAV-393 (1 mM) or Bmp-2 (100 ng/ml) were
added to the media one hour after initiation of culture. Explants
were harvested and processed for RNA isolation after 72 h in
culture.2.9. Micromass culture
Primary MEF cells were obtained from ATCC and cultured in
Dulbecco's modiﬁed Eagle’s medium (GIBCO) supplemented with
20% non-heat inactivated fetal bovine serum (ATCC) along with 1%
Penicillin/Streptomycin. Cells were plated into 12-well plates in
micro-masses consisting of 125,000 cells/10 ml. After three hours,
cells were ﬂooded with culture media. Wnt 3a, Wnt5a, Bmp-2 and
LiCL were added to the media. Cells were harvested after 6 days of
culture and process for RNA isolation.
2.10. RNA Extraction and RT-PCR
Gene expression was determined by quantitative RT-PCR. RNA
was isolated from embryonic tracheal explants using a commer-
cially available kit (RNAeasy mini kit or micro kit, Qiagen-Prome-
ga). Reverse transcription was performed according to manu-
facturer instructions (Verso Fisher Sci), and Taqman probes were
utilized to detect differential expression using a StepOnePlus RT-
PCR System.
2.11. Statistics
Quantitative data were presented as mean7standard error.
Experiments were repeated at least twice with a minimum of
three biological replicates for each group. Statistically signiﬁcant
differences were determined by paired T-test or one-way ANOVA
followed by post hoc pairwise multiple comparison procedures
(Bonferroni method). Signiﬁcance was set at Po0.05.3. Results
3.1. Deletion of Wls from the respiratory tract epithelium caused
tracheobronchomalacia
Wls is expressed in both epithelium and mesenchyme of de-
veloping trachea as determined by in situ hybridization (Fig.1 A).
To deﬁne the role of Wnt signaling in upper airway differentiation
Wls was deleted from the epithelial cells of the embryonic foregut
endoderm by breedingWls CKOmice (Carpenter et al., 2010) to the
Shh Cre mice. Efﬁcient and speciﬁc Cre mediated recombination in
the trachea was demonstrated by detection of GFP in the epithe-
lium of the respiratory tract of embryos at E11.5 after breeding the
ShhCre mice to the Rosa mT/mG reporter mice (Fig.1 B). Deletion of
Wls was conﬁrmed by PCR using primers that recognize the mu-
tant allele in tracheal tissue (Supp. Fig.1). Lungs of Wlsf/f;ShhCre/þ
mice were hypoplastic (Fig.1 F,G compare to C,D) (Cornett et al.,
2013). Tracheal and bronchial, but not laryngeal cartilage was
absent as determined by Alcian blue (Fig.1 C,F) and H&E staining at
E18.5 (Fig.1 D, E, G, H, E' and H'). Cross sections of E18.5
Wlsf/f;ShhCre/þ embryos stained with H&E conﬁrmed the lack of
cartilage in the trachea and the presence of a distinct esophageal
tube. Taken together, these data demonstrate that deletion of Wls
from the epithelium of the developing trachea caused agenesis of
the tracheal and bronchial cartilage, ﬁndings consistent with de-
fects associated with tracheobronchomalacia.
3.2. Canonical Wnt signaling is active in tracheal mesenchyme and is
severely impaired after epithelial deletion of Wls
Wls is a cargo receptor mediating secretion of Wnt ligands
from the producing cells (Banziger et al., 2006). However, it re-
mains unclear whether Wls differentially promotes secretion of
Wnt ligands eliciting β-catenin dependent or independent sig-
naling. To assess whether Wnt ligands produced by the tracheal
Fig. 1. Deletion of Wls from the embryonic foregut endoderm causes tracheal–bronchial cartilage agenesis. In situ hybridization was performed on cross sections of E13.5
embryos. Representative image depicting expression of Wls in trachea and esophagus is shown. Dotted lines demark the tracheal and esophageal epithelium (A). Whole
mount of tracheal lung explant depicting epithelial GFP expression driven by Cre mediated recombinase in Wlsf/f;ShhCre/þ ;Rosa mT/mG mice is shown. Cross section of the
tracheal explant demonstrates the circumferential expression of GFP indicating sites of Cre mediated recombination (B). Alcian blue (C,F) and H & E (D,E,G,H) stainings of
whole mounts and tracheal/lung sections demonstrate the near absence of cartilage in Wlsf/f;ShhCre/þ trachea and bronchi. Higher magniﬁcations of regions in squares are
shown in E and H. Cross sections of control (E') and Wlsf/f;ShhCre/þ (H') E18.5 embryos depict esophagus and trachea. Note the lack of cartilage in Wlsf/f;ShhCre/þ embryos and
the position of trachea in close proximity to the esophagus.
J. Snowball et al. / Developmental Biology 405 (2015) 56–70 59
Fig. 2. Decreased mesenchymal canonical Wnt signaling after deletion of epithelial Wls. X-gal staining was performed on trachea-lung explants of E12.5 Axin2LacZ and
Wlsf/f;ShhCre/þ ;Axin2LacZ mice. X-gal staining was primarily observed in mesenchyme of Axin2LacZ mice, while staining was nearly absent in tissue of Wlsf/f;ShhCre/þ ;Axin2LacZ
mice (A,B). At E14.5, X-gal staining was detected in the tracheal mesenchyme of control embryos in a pattern similar to that of the cartilaginous rings. In contrast, no staining
was detected in the trachea of Wlsf/f;ShhCre/þ embryos (C). E14.5 control tracheal explants were stained with Alcian blue to determine sites of chondrogenesis. The staining
pattern is similar to the X-gal staining of Axin2LacZmice (D). X-gal staining was restricted to the periphery of tracheal mesenchymal condensations (E, F). In situ hybridization
was performed to determine expression pattern of several Wnt ligand mRNA. At E11.5 Wnt5a was detected in both epithelium and mesenchyme of developing trachea. At
E13.5 Wnt5a RNA was enriched in the ventral mesenchyme of developing trachea, while Wnt7b was restricted to the epithelium of E11.5 and E13.5 trachea (G). Wnt2 and
Wnt2b mRNAwere detected in dorsal and lateral mesenchyme surrounding the trachea.Wnt4mRNA was detected at low levels in the tracheal epithelium, while Wnt11 was
present in tracheal mesenchyme of E13.5 embryos (H).
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Fig. 3. Loss of epithelial Wls-mediated signaling disrupts dorsal–ventral patterning of the trachea. Longitudinal and cross sections of E13.5 (A,B) and E14.5 (C,D,E,F) embryos
were stained with Sox9, aSMA and Nkx2.1 antibodies. DAPI was utilized to visualized cell nuclei. Sox9 was absent in the tracheal mesenchyme but expressed in vertebre
cartilage of Wlsf/f;ShhCre/þ embryos. αSMA staining was expanded into the ventral region of the trachea of Wlsf/f;ShhCre/þ embryos (B,D,F). In developing trachea of
Wlsf/f;ShhCre/þ embryos, muscle ﬁbers run parallel to the longitudinal axis of the trachea in contrast to the transversal arrangements of the ﬁbers observed in control trachea
(E', F'). Sox9 was decreased and Acta2 mRNA increased in tracheal explants of Wlsf/f;ShhCre/þ embryos at E14.5 (G). N¼4, **po0.01, T-trachea Es¼esophagus.
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Fig. 4. Epithelial Wls is required for prechondrogenic mesenchymal condensations. Tracheal lung explants of E13.5 embryos were stained with PNA lectin. Lack of staining
demonstrates absence of mesenchymal condensations in tracheas of Wlsf/f;ShhCre/þ embryos (arrow B vs. arrow A). Insets in A and B correspond to bright ﬁeld images of
whole mounts stained with PNA lectin. Confocal images of E13.5 whole mounts show decreased Sox9 staining in tracheal mesenchyme (arrow in C, and D). Sox9 staining in
cells of the peripheral lung overlapped with Nkx2.1 in both control and Wlsf/f;ShhCre/þ pulmonary tissue (arrowhead in G and H). Es¼esophagus, Br¼Bronchus, Sp¼spine.
J. Snowball et al. / Developmental Biology 405 (2015) 56–7062epithelium induce canonical Wnt response, Wlsf/f;ShhCre/þ mice
were crossed to Axin2Lac-Z mice. Axin2 promoter activity was
decreased after deletion of Wls from the epithelium. X-gal staining
was present in the subepithelial mesenchymal cells of conducting
airways and lung periphery of E12.5 control embryos. In contrast,
no staining was detected inWlsf/f;ShhCre/þ embryos (Fig. 2A and B).
At E14.5, X-gal staining was detected in the mesenchyme of the
trachea resembling the pattern of cartilaginous rings (Fig. 2C).
Alcian blue staining and Axin2 promoter activity were present in
the tracheal mesenchyme at sites of chondrogenesis (Fig. 2D and
E); however, Axin2 LacZ staining was excluded from mesenchymal
condensations and was conﬁned to the sub-epithelial mesench-
yme of developing trachea (Fig.2F). Similarly to ﬁndings at E12.5,
Axin2 promoter activity was not detected in tracheas of E14.5
Wlsf/f;ShhCre/þ embryos (Fig. 2C).
While the expression pattern of Wnt ligands in developing lung
is well established, less is known about the temporal–spatialexpression of Wnt ligands in the trachea. At E11.5 Wnt5a was
expressed in both epithelium and mesenchyme of the trachea.
Wnt7b was expressed in a circumferential pattern in tracheal
epithelium of E11.5 and E13.5 embryos. In contrast, by E13.5
Wnt5a was expressed predominantly in ventral mesenchyme of
the trachea, but it was also detected to lesser degree in the epi-
thelium of the trachea (Fig. 2G). At E13.5 Wnt2 and Wnt2b were
present in tracheal mesenchyme. Wnt2b was enriched in the
dorsal and lateral regions of the tracheal mesenchyme. Wnt2 and
Wnt2b were also detected in the mesenchyme of the developing
distal lung (Supplementary Fig. 2). Wnt4 and Wnt11 were detected
at low levels in the epithelium and mesenchyme of the trachea
respectively (Fig. 2H). Wnt11 was also detected in ventral body
wall conﬁrming our previous studies (Supplementary Fig. 2)
(Snowball et al., 2015). In situ probes recognizing a housekeeper
gene Ppib and a bacterial gene Dapb, were run in parallel and
served as a positive and negative experimental control
Fig. 5. Epithelial Wnt ligands modulate mesenchymal cell proliferation. Confocal images of E11.5 tracheal lung explants stained for Sox9 and Nkx2.1 are shown. Sox9 staining
was nearly absent in the tracheal mesenchyme of Wlsf/f;ShhCre/þmice. Transverse sections of tracheal tissue depict the extent of Sox9 expression and the lack of aSMA
staining in Wlsf/f;ShhCre/þ at E11.5. Dams were injected at E11.5 with BrdU to determine cell proliferation. Longitudinal sections of E12.5 tracheas were stained for BrdU and
Nkx2.1; proliferation was decreased in mesenchyme of Wlsf/f;ShhCre/þ embryos (B,C). Smooth muscle cell proliferation was increased at E13.5, while proliferation of Sox9
stained cells was reduced in the tracheal mesenchyme of Wlsf/f;ShhCre/þ embryos (D, E). Increased numbers of αSMA stained cells were found in direct apposition to the
tracheal epithelium. Numbers of Sox9 stained cells in direct contact with the tracheal epithelium were signiﬁcantly reduced (F).
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J. Snowball et al. / Developmental Biology 405 (2015) 56–7064(Supplementary Fig. 2). Data presented demonstrate that epithelial
Wls is required for Wnt/β-catenin signaling in developing tracheal
mesenchyme and that Wnt7b and Wnt5a are abundantly ex-
pressed in the E11.5 tracheal epithelium where they are likely to
participate in mesenchymal tracheal patterning downstream of
Wls.
3.3. Epithelial Wls regulates dorsal ventral patterning of the tracheal
mesenchyme
Since epithelial deletion of Wls drastically impaired cartilage at
E18.5, we sought to identify the timing of cartilage and smooth
muscle patterning at earliest stages. In the mouse, tracheal carti-
lage is well formed by E15 (Park et al., 2010; Tiozzo et al., 2009). At
E13.5 in Wlsf/f;ShhCre/þ embryos smooth muscle layer, detected by
αSMA staining, was expanded into the ventral aspect of the tra-
chea and cartilage was absent (Fig. 3A and B). At E14.5, the precise
patterning of the normal trachea in control mice was evidenced by
a dorsal stripe of muscle. Cartilage was present as partial cir-
cumferential rings on the ventral side of the trachea. In contrast, in
tracheas of Wlsf/f;ShhCre/þmice, αSMA staining was expanded to
the ventral side of the trachea (Fig. 3C, D, E and F). Epithelial cells
lining the trachea stained for TTF-1 in Wlsf/f;ShhCre/þ embryos,
demonstrating maintenance of respiratory epithelial cell identity.
In Wlsf/f;ShhCre/þembryos, the orientation of muscle ﬁbers was
disrupted and organized parallel to the longitudinal axis of the
trachea. In contrast, in control embryos, muscle ﬁbers of the tra-
chealis muscle were oriented transversally to the longitudinal axis
of the trachea (Fig. 3 E' versus F'). Few Sox9 stained cells were
observed randomly scattered throughout the dorsal mesenchyme
of the Wlsf/f;ShhCre/þtracheas (Fig. 3F’). These cells were also po-
sitive for Sox10 (data not shown). At E18.5, virtually no Sox9 po-
sitive cells were present in the tracheal mesenchyme (Supple-
mentary Fig. 3). Sox9 transcripts were diminished while Acta2
transcripts were increased in tracheal tissue isolated from
Wlsf/f;ShhCre/þembryos (Fig. 3G). These ﬁndings are in agreement
with the previously described expression proﬁle of Sox9 and
αSMA in Wlsf/f;ShhCre/þtracheas. These data support the concept
that Wnt ligands, dependent upon Wls secretion from en-
dodermally derived cells, promote cartilage formation and may
repress smooth muscle on the ventral side of the trachea, as well
as inﬂuence the arrangement of tracheal smooth muscle.
3.4. Epithelial Wnt signaling regulates Sox9, mesenchymal cell pro-
liferation and mesenchymal cells condensations
A critical event during cartilage formation is the condensation
of mesenchymal cells into chondrogenic nodules (Bi et al., 1999). In
developing trachea, condensations are established by E13.5. Whole
mount tracheal lung explants were stained with PNA (Peanut
Agglutinin Lectin) to label condensing cells (Gillotte et al., 2003).
At E13.5, a clear pattern of condensed mesenchymal cells resem-
bling cartilaginous rings was readily distinguished (Fig. 4A, arrow),
while in Wlsf/f;ShhCre/þtracheas condensations were seldom de-
tected (Fig. 4B, arrow). These data were supported by whole
mount staining of control tracheal lung explants wherein Sox9 was
strongly expressed in mesenchymal condensations (Fig. 4C, ar-
row). In contrast, in tracheas of Wlsf/f;ShhCre/þ embryos Sox9
staining was weakly detected in subepithelial mesenchyme
(Fig. 4D arrow). Sox9 was strongly expressed in the respiratory
epithelium of the lung (arrow head in Fig. 4E and F). These data
indicate that epithelial Wls is required for signaling to tracheal
mesenchymal cells to inﬂuence Sox9 expression and to form me-
senchymal condensations on the ventral side of the trachea.
At E11.5, Sox9 staining was present in the tracheal mesench-
yme of control and reduced in Wls deﬁcient embryos (Fig. 5A).Since Wnt signaling modulates cell proliferation, we reasoned that
the lack of Sox9 positive cells could be related to decreased me-
senchymal cell proliferation or increased cell death. At E12.5, cell
proliferation was decreased in the mesenchyme of the
Wlsf/f;ShhCre/þ tracheas (Fig. 5B and C). To test whether loss of
epithelial Wls mediated signaling differentially affected prolifera-
tion of chondroblasts or myoblasts, we quantiﬁed cells expressing
Sox9 or αSMA in cross sections of tracheas from E13.5 embryos.
BrdU labeling demonstrated increased numbers of αSΜΑ but
decrease numbers of Sox9 proliferating cells. Likewise, numbers of
Sox9 stained cells were decreased and those staining for αSMA
stained cells were increased (Fig. 5D and E). Moreover, the number
of Sox9 stained cells in close apposition with the tracheal epi-
thelium was decreased and αSMA stained mesenchymal cells in
close proximity to the tracheal epithelium were increased in
Wlsf/f;ShhCre/þembryos, demonstrating the malpositioning of
muscle cells on the ventral side of the trachea (Fig. 5F). TUNEL
studies did not detect differences in cell death between controls
and Wlsf/f;ShhCre/þ tracheal tissue (data not shown). Thus, these
data demonstrate that epithelial Wls controls mesenchymal cell
proliferation, modulating proliferation and numbers of chondro-
genic and myogenic cells in the embryonic tracheal mesenchyme.
3.5. Mesenchymal deletion of Sox9 is not sufﬁcient to promote ex-
pansion of tracheal smooth muscle
To assess whether Wls effects on tracheal mesenchyme pattern-
ing depend on Sox9, we deleted Sox9 from the developing tracheal
mesenchyme using Dermo1Cre and Col2a1Cre mice. Deletion of Sox9
from the mesenchyme of the trachea using Dermo1Cremice, reduced
the number and altered the shape of cartilaginous rings, resulting in
a shorter trachea, ﬁndings resembling the Wnt5a loss of function (Li
et al., 2002) (Supplementary Fig. 4H). Col2a1 is a direct target of Sox9
and it is expressed in developing trachea at E10.5 in a similar dis-
tribution to that of Sox9 (Elluru et al., 2009; Elluru and Whitsett,
2004). We utilized Col2a1Cre mice to delete Sox9 in chondrocyte
progenitors. While cartilage formation was severely impaired, dele-
tion of Sox9 did not cause robust expansion of the muscle layer into
the ventral side of the trachea (Fig. 6B, D, F, H and Supplementary
Fig. 4F), ﬁndings contrasting the phenotype observed in
Wlsf/f;ShhCre/þ embryos (Fig. 3B). We also determined that Acta2 le-
vels were not altered in tracheas of E14.5 Sox9f/f;Col2a1Cre/þ embryos
(Fig. 6I). These data demonstrate that while Sox9 is required for
tracheal cartilage development, deletion of Sox9 did not cause ex-
pansion of the muscle layer into the ventral side of the trachea as
seen in the Wlsf/f;ShhCre/þ embryos.
To test whether mesenchymalWls inﬂuenced tracheal patterning,
Wls was conditionally deleted using Dermo1Cre mice. Dermo1Cre
efﬁciently targets the mesenchyme surrounding the E10.5 foregut as
well as mesenchyme of the E12.5 developing trachea, as veriﬁed by
GFP staining in Dermo1-Cre;Rosa mT/mG mice (Supplementary
Fig. 5A). Neither Sox9 mRNA nor staining were altered by me-
senchymal deletion of Wls (Supplementary Fig. 5). Expression levels
and pattern of αSMA staining were unaltered. Deletion of Wls from
chondrocyte precursors, using Col2a1Cremice did not affect cartilage
formation or tracheal patterning (Supplementary Fig. 5). These data
suggest that secretion of mesenchymal Wnt ligands may play a re-
dundant role in regards to tracheal patterning, supporting the con-
cept that the epithelial Wls mediated signaling directs mesenchymal
patterning of the trachea.
3.6. Canonical Wnt signaling modulates Sox9 in prechondrogenic
tracheal explants
It is established that canonical Wnt signaling modulates Sox9
activity during endochondral bone formation (Akiyama et al.,
Fig. 6. Mesenchymal deletion of Sox9 from developing trachea does not promote expansion of tracheal muscle layer. Sox9 was deleted using Col2a1Cre mice, resulting in
tracheal cartilage agenesis (B,D,F). No expansion of muscle into the ventral mesenchyme of the trachea was observed (D,F,H). RT-PCR analysis demonstrates that Sox9 mRNA
is decreased while Acta2 mRNA was not signiﬁcantly changed in E14.5 Sox9f/f;Col2a1Cre/þ trachea (I). N ¼ 4 **po0.01.
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Fig. 7. Canonical Wnt signaling modulates expression of Sox9 ex vivo and in vitro. Bmp-2 (100 ng/ml) induced Sox9 expression in Wlsf/f;ShhCre/þ tracheal explants, while
Wnt3a or Wnt5a (200 ng/ml) did not induce Sox9 in tracheal explants. (A) Addition of Wnt3a and Wnt5a to culture media of Wlsf/f;ShhCre/þ explants increased Sox9 and
Col2a1 mRNA (B). Control tracheal explants were cultured in the presence of the canonical Wnt antagonist XAV-939. Addition of XAV-939 (1 mM) reduced expression of
Col2a1, Lef1 (a direct canonical Wnt target) and to lesser degree Sox9 (C). In MEF micromass cultures, addition of Bmp-2 robustly induced Sox9 and Col2a1. Addition of Bmp-2
and LiCl repressed Bmp-2 induced Sox9 in MEF micromasses (D). N¼5 *po0.05 **po0.02 vs. C.
J. Snowball et al. / Developmental Biology 405 (2015) 56–70662004; Day and Yang, 2008; Hill et al., 2005). To test the hypothesis
that epithelial Wnt signaling regulates Sox9 expression to induce
tracheal chondrogenesis, we utilized ex vivo tracheal explants
cultures. We tested whether Wlsf/f;ShhCre/þ tracheal explants iso-
lated at E11.5 and incubated for 72hrs. were responsive to Bmp-2,
a chondrogenic signal (Lengner et al., 2004; Pan et al., 2008). Bmp-
2 induced Sox9 and Col2a1 expression. Neither addition of Wnt3a
(a Wnt ligand that similarly to Wnt7b typically induces Wnt/β-
catenin signaling in respiratory tract) nor Wnt5a alone induced
Sox9 in tracheal explants (Fig. 7A); however, addition of both li-
gands to the culture media robustly induced Sox9 and to lesser
degree Col2a1 (Fig. 7B). Acta2 mRNA was not signiﬁcantly changed
by addition of Wnt3a or Wnt5a (Fig. 7A and B). When E11.5 control
tracheal explants were incubated in the presence of Wnt canonical
signaling inhibitor XAV 939 (Huang et al., 2009), Sox9 expression
was modestly decreased and Col2a1 was sharply decreased
(Fig. 7C). To test if Wnt signaling modulates Sox9 expression after
formation of mesenchymal condensations, MEF (mouse embryonic
ﬁbroblasts) cells were seeded in micromasses and treated with
Bmp-2 to induced Sox9 (Lengner et al., 2004). In this system, in-
cubation in presence of LiCl, an activator of Wnt/β-catenin sig-
naling (Klein and Melton, 1996), repressed Sox9 and Col2a1 and
did not alter Acta2 (Fig. 7D). Similar results were obtained when
tracheal explants isolated at E13.5 (stage when mesenchymal
condensations are formed), were treated with LiCl resulting in
decreased Sox9 and Col2a1 mRNAs (data not shown). These data
suggest that Wnt/β-catenin signaling plays differential roles dur-
ing tracheal chondrogenesis, and that Wnt signaling is necessary
to promote Sox9 and Col2a1 in prechondrogenic tracheal me-
senchyme ex vivo.3.7. Epithelial Wls mediated signaling is necessary for expression of
factors required for tracheal patterning of cartilage and muscle
Since addition of Bmp-2 induced Sox9 and Col2a1 in explants
and in micromass cultures, we asked whether BMP signaling was
altered in tracheas of Wlsf/f;ShhCre/þ embryos. Bmp4 and Bmp6
mRNA levels were modestly decreased in the mesenchyme of
developing tracheas of E11.5 and E13.5 Wlsf/f;ShhCre/þ as de-
termined by quantitative RT-PCR and in situ hybridization (Fig. 8A
and B). Furthermore, treatment of tracheal explants from
Wlsf/f;ShhCre/þ embryos with Bmp-2, strongly induced Sox9 ex-
pression (Fig. 7A). Msx1, Msx2, Tbx4 and Tbx5, transcription factors
known to inﬂuence cartilage and smooth muscle development,
were reduced in Wlsf/f;ShhCre/þ tracheal tissue (Fig. 8A and B). At
E13.5 Wls mRNA was decreased in the tracheal mesenchyme of
Wlsf/f;ShhCre/þ as determined by in situ hybridization, suggesting
that Wls may inﬂuence its own expression (Fig. 8B). To test whe-
ther Wnt/β-catenin signaling modulated the expression of genes
regulating chondrogenesis ex vivo, control tracheal explants iso-
lated at E11.5 were incubated with XAV 939 for 72 h. resulting in
decreased expression of Msx2, Tbx4 and Tbx5 (Fig. 8C). Taken to-
gether, these data support the concept that epithelial Wls inﬂu-
ences expression of genes required for cartilage differentiation at
least in part, via canonical Wnt signaling.4. Discussion
In the present study, we demonstrated that endodermal Wls
mediated signaling is required for tracheal cartilage development.
Fig. 8. Canonical Wnt signaling inﬂuences expression of genes controlling cartilage differentiation. Quantitative RT-PCR performed on E11.5 and E13.5 tracheas of control and
Wlsf/f;ShhCre/þ embryos demonstrated decreased expression of genes required for cartilage patterning, as well as increased levels of Acta2 at E13.5, N ¼ 3 *po0.05, **po0.01
(A). Analysis of Wls, Bmp4 and Msx2 mRNA by in situ hybridization is shown. Bmp4 and Msx2 localized to the ventral region of the trachea where cartilage will be formed.
Epithelial deletion of Wls decreased Bmp4 and Msx2 mRNA in ventral tracheal mesenchyme. Wls RNA was decreased in tracheal epithelial cells of Wlsf/f;ShhCre/þ mice. Ppib
transcripts, positive control, were detected throughout the section while Dapb transcripts, negative control, were not detected (B). Incubation of tracheal explants with XAV-
939 decreased Msx2, Tbx4 and Tbx5 and Lef1 mRNAs. Representative experiments of explant cultures are shown. N¼3 *po0.05 (C). T¼Trachea, Br¼Bronchus.
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J. Snowball et al. / Developmental Biology 405 (2015) 56–7068Epithelial Wls inﬂuenced the expression of pro-chondrogenic
genes in part by activation of Wnt/β-catenin signaling in tracheal
mesenchyme. Epithelial Wls mediated signaling limited the pro-
liferation of muscle layer into the ventral and lateral regions of the
trachea. Therefore, precise regulation of Wnt ligand secretion from
the tracheal bronchial epithelium is required for normal pattern-
ing of tracheal–bronchial cartilage.
4.1. Initiation of the chondrogenic program in developing trachea
requires Wnt signaling
While commitment of tracheal mesenchymal cells towards the
chondrogenic lineage is deﬁned by the expression of Sox9, the
events upstream of Sox9 expression are less well understood.
Present data demonstrated that epithelial Wls is required for Sox9
expression and formation of tracheal cartilage (Figs. 1 and 3). We
determined that Wnt/β-catenin signaling was operative in the
sub-epithelial mesenchyme of the trachea of control embryos, and
that epithelial deletion of Wls severely impaired Wnt/β-catenin
activity in the tracheal mesenchyme of Wlsf/f;ShhCre/þ embryos
(Fig. 2).
Our data support the concept that epithelial Wls inﬂuences
gene expression required for chondrogenesis. Expression of Bmp4
and Bmp6 was reduced, to some extent, in Wlsf/f;ShhCre/þ em-
bryos. It has been shown that BMP signaling plays a critical role in
cartilage formation during limb development (Barna and Nis-
wander, 2007; Duprez et al., 1996; Karamboulas et al., 2010). At
early stages of respiratory tract development, Bmp4 is expressed in
the anterior foregut and it is required for outgrowth of the trachea
(Li et al., 2008). Moreover, Bmp4 is expressed in the ventral region
of the prechondrogenic tracheal mesenchyme (this study and
(Park et al., 2010), where cartilage will be formed. Our studies
showed that Bmp-2 (a ligand with 80% homology to Bmp-4) in-
duced Sox9 expression in tracheal explants of control and
Wlsf/f;ShhCre/þ embryos (Fig. 7A). Present data also suggest that in
tracheal development, both Bmp and Wnt signaling inﬂuence the
differentiation of tracheal mesenchyme into cartilage (Figs. 7 and
8). These data are supported by recent studies demonstrating that
the interplay between Bmp and Wnt signaling determines the
sites of expression of Sox9 during patterning of digits (Raspopovic
et al., 2014). Our data also demonstrated that epithelial Wls is
necessary for Tbx4 and Tbx5 expression. Tbx4 and Tbx5, are known
to promote tracheal cartilage development by inducing Sox9 ex-
pression as well as promoting mesenchymal condensations (Arora
et al., 2012). It is unclear whether Tbx4 and Tbx5 are direct targets
of Wnt signaling. Our in vitro studies showed that pharmacological
inhibition of Wnt/β-catenin signaling in prechondrogenic control
tracheal explants decreased the mRNA levels of Sox9, Col2a1, Tbx4
and Tbx5 thus conﬁrming the requirement of canonical Wnt sig-
naling in the tracheal mesenchyme for establishment of the
chondrogenic program (Fig. 8). These data are in agreement with
the concept that Wnt signaling plays a dynamic role in cartilage
development and both anomalously increased or diminished le-
vels of Wnt signaling will disrupt chondrogenesis (Ling et al.,
2009; Liu et al., 2008). Previous in vivo and in vitro studies suggest
that β-catenin activity ﬂuctuates during chondrogenesis, being
higher in prechondrogenic mesenchyme, and at lower levels dur-
ing chondrocyte maturation (Gaur et al., 2006; Ling et al., 2009).
4.2. Wnt ligands act synergistically to induce tracheal cartilage
Wls is required for secretion and activity of all lipid modiﬁed
Wnt ligands (Najdi et al., 2012). Our studies shown that Wnt7b,
Wnt5a and to lesser degree Wnt4 transcripts were found in a cir-
cumferential expression pattern in the tracheal epithelium at E11.5
(Fig. 2). Deletion of Wnt7b was associated with abnormalcartilaginous rings (Rajagopal et al., 2008). Mice carrying a null
allele of Wnt5a developed a short trachea with anomalous, dis-
continuous cartilaginous rings (Li et al., 2002), resembling the
tracheal phenotype observed in Sox9f/f;Dermo1Cre/þ mice. It is
presently unknown whether Wnt4 participates in tracheal pat-
terning, however mutations in WNT4 are associated with lung
hypoplasia (Mandel et al., 2008). Thus, the lack of cartilage ob-
served in tracheas of Wlsf/f;ShhCre/þ embryos may result from the
combined loss of Wnt7b and Wnt5a signaling, a model supported
by our in vitro data, wherein addition of both Wnt3a and Wnt5a
induced expression of Sox9 and Col2a1 in Wlsf/f;ShhCre/þ tracheal
explants. Thus Wnt/β-catenin activity induced by epithelial Wnt
ligands is required, at least in part, for commitment of mesench-
ymal cells towards the chondrogenic lineage (Figs. 7 and 8).
4.3. Wnt signaling is required for differentiation and patterning of the
trachealis muscle
It is unknown how the muscle lineage is initially speciﬁed in
the tracheal mesenchyme. In peripheral lung, Wnt7b and Wnt2
play essential roles in establishment of vascular and airway
smooth muscle (Cohen et al., 2009; Goss et al., 2011). In our model,
deletion of Wls from the epithelium of the trachea resulted in
expansion of muscle layer into the ventral aspect of the trachea
ﬁndings not seen in other experimental models of tracheomalacia
(Hines et al., 2013; Turcatel et al., 2013). Our studies showed that
deletion of Sox9 from tracheal mesenchyme using the Col2a1Cre
mice caused severe loss of cartilage; however, expansion of αSΜΑ
staining into the ventral side of the trachea was not observed
(Fig. 6). Epithelial deletion of Wls caused a sharp change in pro-
liferation proﬁle, resulting in increased proliferation of αSΜΑ
stained cells (myoblasts) accompanied by decreased proliferation
of Sox9 stained cells (chondroblasts). This proliferation proﬁle
contrasts with that observed in control developing tracheas,
wherein Sox9 stained cells (chondroblasts) proliferation is higher
when compared to αSMA stained cells (myoblasts) proliferation
(Fig. 5). Thus, epithelial Wls inﬂuences mesenchymal cell pro-
liferation to balance myoblast and chondroblast growth in devel-
oping trachea.
Wnt signaling may pattern tracheal muscle by inducing genes that
antagonize muscle development in the ventral mesenchyme of the
trachea. The transcription factors Msx1 and Msx2, targets of BMP sig-
naling and known to play many roles in embryonic development,
were expressed in the ventral aspect of the trachea (Alappat et al.,
2003; Ishii et al., 2005). Msx1 and Msx2 were decreased in
Wlsf/f;ShhCre/þ tracheal tissue. Msx2 mRNA was decreased in control
prechondrogenic tracheal explants incubated with the canonical Wnt
inhibitor XAV 939 (Fig. 8). Studies on vascular development and dis-
ease have shown that Msx1 and Msx2 actively repressed smooth
muscle differentiation (Cheng et al., 2014; Hayashi et al., 2006; Lalle-
mand et al., 2005). Thus, these data suggest that Msx1 and Msx2 may
antagonize the formation of smooth muscle in the ventral mesench-
yme of the trachea.
Besides effects in tracheal muscle patterning, deletion of epi-
thelial Wls changed the orientation of the muscle ﬁbers of the
trachealis muscle, being oriented parallel to the longitudinal tra-
cheal axis, rather than the transverse orientation observed in
trachealis muscle of control embryos (Fig. 3). This abnormal ar-
rangement of the muscle layer resembles the phenotype pre-
viously described by deletion of the transmembrane protein Tmem
16; however, in the latter model of tracheomalacia, expansion of
muscle into the ventral aspect of the trachea was not described
(Rock et al., 2008). Thus, Wnt signaling from the epithelium plays
a dual role in trachealis muscle development: preventing muscle
differentiation in the ventral tracheal mesenchyme and being re-
quired for normal morphology of the trachealis muscle ﬁbers.
Fig. 9. Model for dorsal ventral patterning of developing trachea. Epithelial Wls
promotes cartilage development and prevents the expansion of muscle cells into
the ventral side of the trachea. Wnt ligands produced by the epithelium promote
canonical Wnt signaling in the tracheal mesenchyme, inﬂuencing the expression of
transcription factors required for differentiation of mesenchymal cells into carti-
lage. Epithelial Wls regulates mesenchymal proliferation and modulates prolifera-
tion of smooth muscle cells. Thus, by promoting cartilage differentiation and
modulating smooth muscle cell proliferation, epithelial Wnt signaling directs the
patterning of the tracheal mesenchyme.
J. Snowball et al. / Developmental Biology 405 (2015) 56–70 69In conclusion, we propose a model wherein epithelial Wnt
signaling from endodermal progenitors of the respiratory tract
mediates dorsal ventral patterning of the trachea. Epithelial Wnt
ligands including Wnt7b and Wnt5a activate Wnt/β-catenin in the
mesenchyme of the developing trachea to inﬂuence expression of
chondrogenic factors including Tbx4, Tbx5 Msx1 Msx2 Sox9 and
Col2a1, genes required for initiation of chondrogenesis in the
ventral region of the trachea. Epithelial Wls also differentially
promotes cell proliferation of mesenchymal cells and prevents the
anomalous proliferation of muscle cells into the ventral region of
the trachea. By inﬂuencing differentiation of pre-chondrogenic
mesenchyme and cell proliferation, epithelial Wnt ligands direct
dorsal ventral patterning of developing trachea (Fig. 9). Taken to-
gether, abnormalities in secretion of Wnt ligands produced by the
epithelial cells of the upper airways, provides a mechanism un-
derlying congenital tracheobronchomalacia.Acknowledgments
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